1Y Target$22.25Near-term target
5Y Target$23.87Compound horizon
10Y Target$62.13Long-dated conviction
FCF——FCF not applicable for this sector (bank / insurer / REIT) or data unavailable
Rev+15.0%TTM YoYB+Revenue +15.0% — above sector median, healthy trajectory
D/E0.02AD/E 0.02 — essentially debt-free, pristine balance sheet
P/S1.1xA-P/S 1.1x — cheap for any tech/growth name
PEG——PEG not meaningful — earnings growth negative or data unavailable
Why now
Health Information Services · market cap $3.3b. Down 42% from 52-week high of $20.48 — deep drawdown territory. Revenue growing +15%, comfortably above the S&P median. 12 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $22.25 (implying +87% upside).
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -10.7%) — path to GAAP profitability is the core thesis risk. Down 42% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up.
Horizon
1-3 yr $22.25 (12-analyst consensus) — catalyst-driven; binary events dominate. 5 yr $23.87 — requires the platform / technology to reach commercial scale. 10 yr $62.13 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.